BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3481749)

  • 1. Persistence of CML despite deletion of rearranged bcr/c-abl sequences.
    Bartram CR; Janssen JW; Becher R
    Haematol Blood Transfus; 1987; 31():145-8. PubMed ID: 3481749
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis.
    Bartram CR; Janssen JW; Becher R; de Klein A; Grosveld G
    J Exp Med; 1986 Nov; 164(5):1389-96. PubMed ID: 3464689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired homozygosity of the rearranged bcr allele during the acute leukemic phase of a patient with Ph-negative chronic myeloid leukemia.
    Reeve AE; Morris CM; Fitzgerald PH
    Blood; 1988 Jul; 72(1):24-8. PubMed ID: 3164635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myelogenous leukemia: amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis.
    Collins SJ; Groudine MT
    Blood; 1987 Mar; 69(3):893-8. PubMed ID: 3545323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
    Collins SJ
    J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional c-abl/bcr rearrangements in a CML patient exhibiting two ph1 chromosomes during blast crisis.
    Bartram CR; de Klein A; Hagemeijer A; Carbonell F; Kleihauer E; Grosveld G
    Leuk Res; 1986; 10(2):221-5. PubMed ID: 3005778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characteristics of chronic myelogenous leukemia in blast crisis.
    Blick M; Romero P; Talpaz M; Kurzrock R; Shtalrid M; Andersson B; Trujillo J; Beran M; Gutterman J
    Cancer Genet Cytogenet; 1987 Aug; 27(2):349-56. PubMed ID: 3474057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in expression of the bcr-abl fusion transcript in CML blast crisis.
    Andrews DF; Collins SJ
    Leukemia; 1987 Oct; 1(10):718-24. PubMed ID: 3312834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transposition of c-abl oncogene in a case of masked Ph chromosome duplicated in blastic phase.
    Maserati E; Cavalli P; Casalone R; Morandi S; Pasquali F
    Hum Genet; 1988 Mar; 78(3):248-50. PubMed ID: 3162225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Philadelphia-positive chronic myelogenous leukemia with breakpoint 5' of the breakpoint cluster region but within the bcr gene.
    Bartram CR; Bross-Bach U; Schmidt H; Waller HD
    Blut; 1987 Dec; 55(6):505-11. PubMed ID: 3480009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ph-positive chronic myeloid leukemia with loss of the segment distal to M-bcr.
    Pedersen B; Bartram CR; Nielsen JL
    Genes Chromosomes Cancer; 1992 Jan; 4(1):92-3. PubMed ID: 1377017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isochromosome i(22q-) confirmed by in situ hybridization of V-abl gene in a case of CML in blast crisis].
    Takimoto Y; Sakatani K; Kuramoto A; Tanaka K; Oguma N; Kamada N
    Rinsho Ketsueki; 1986 Nov; 27(11):2155-61. PubMed ID: 3469436
    [No Abstract]   [Full Text] [Related]  

  • 14. Undetectable bcr-abl rearrangements in some CML patients are due to a deletion mutation in the bcr gene.
    Hirosawa S; Aoki N; Matsushime H; Shibuya M
    Am J Hematol; 1988 May; 28(1):33-6. PubMed ID: 2835901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. bcr Rearrangement without juxtaposition of c-abl in chronic myelocytic leukemia.
    Bartram CR
    J Exp Med; 1985 Dec; 162(6):2175-9. PubMed ID: 2415665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Philadelphia chromosome-positive chronic myelogenous leukemia with deleted fusion of BCR and ABL genes.
    Ohyashiki K; Ohyashiki JH; Iwabuchi H; Tauchi T; Iwabuchi A; Toyama K
    Jpn J Cancer Res; 1990 Jan; 81(1):35-42. PubMed ID: 2157692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do oncogenes determine clinical features in chronic myeloid leukaemia?
    Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
    Lancet; 1987 Jun; 1(8547):1402-5. PubMed ID: 2884497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome.
    Stam K; Heisterkamp N; Grosveld G; de Klein A; Verma RS; Coleman M; Dosik H; Groffen J
    N Engl J Med; 1985 Dec; 313(23):1429-33. PubMed ID: 3864009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ph-positive chronic myelogenous leukemia with a 5q-chromosome abnormality terminating in erythroblastic crisis.
    Maekawa T; Misawa S; Taniwaki M; Takino T; Sonoda Y; Abe T
    Cancer Genet Cytogenet; 1988 Sep; 34(2):261-3. PubMed ID: 3165699
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular genetics of the pathogenesis and classification of chronic myelocytic leukemia].
    Bartram CR
    Onkologie; 1987 Jun; 10(3):127-32. PubMed ID: 3306531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.